Liberty Global Q4 Loss Narrows

Liberty Global (LBTYA, LBTYB and LBTYK) reported that its fourth-quarter net loss attributable to shareholders narrowed to $1.03 billion from $1.39 billion last year.

Revenue for the quarter increased 14.9% to $3.43 billion from the prior year, primarily driven by the impact of the acquisition of Sunrise, positive foreign exchange movements, mainly related to the strengthening of the British Pound, Euro and Swiss Franc against the U.S. dollar and organic revenue contraction.
Rebased revenue declined 0.5% in the fourth-quarter.

Looking ahead to 2021, the company anticipates modest rebased revenue increases in its four largest markets (UK, CH, NL, BE) as customer growth, price increases and B2B services continue the momentum experienced in 2020.

During the fourth-quarter, the company gained 56,000 customer relationships, as compared to a loss of 26,000 in the prior-year period, representing best quarter over quarter performance for consolidated operations in the past 5 years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT